{
  "url": "https://openlegislation.uk/eu-regulation-2011-440/annex-I",
  "json_url": "https://openlegislation.uk/eu-regulation-2011-440/annex-I.json",
  "legislation": "eur/2011/440",
  "legislation_title": "Commission Regulation (EU) No 440/2011 of 6 May 2011 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to children’s development and health (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2011-440",
  "path": "annex/I",
  "kind": "annex",
  "number": "I",
  "heading": null,
  "text": "Permitted health claims\nApplication – Relevant provisions of Regulation (EC) No 1924/2006\nApplicant – Address\nNutrient, substance, food or food category\nClaim\nConditions of use of the claim\nConditions and/or restrictions of use of the food and/or additional statement or warning\nEFSA opinion reference\nArticle 14(1)(b) health claim referring to children’s development and health\nMead Johnson & Company, 3 rue Joseph Monier-BP 325, 92506 Rueil-Malmaison Cedex, France\nDocosahexaenoic acid (DHA)\nDocosahexaenoic acid (DHA) intake contributes to the normal visual development of infants up to 12 months of age.\nInformation shall be given to the consumer that the beneficial effect is obtained with a daily intake of 100 mg of DHA.\nWhen the claim is used on follow-on formula, the food shall contain at least 0,3 % of the total fatty acids as DHA.\nQ-2008-211, Q-2008-688, Q-2008-689\nArticle 14(1)(b) health claim referring to children’s development and health\nMerck Selbstmedikation GmbH, Roesslerstrasse 96, 64293 Darmstadt, Germany\nDocosahexaenoic acid (DHA)\nDocosahexaenoic acid (DHA) maternal intake contributes to the normal development of the eye of the foetus and breastfed infants.\nInformation shall be given to pregnant and lactating women that the beneficial effect is obtained with a daily intake of 200 mg of DHA in addition to the recommended daily intake for omega-3 fatty acids for adults, i.e. 250 mg DHA and eicosapentaenoic acid (EPA).\nThe claim can be used only for food which provides a daily intake of at least 200 mg DHA.\nQ-2008-675\nArticle 14(1)(b) health claim referring to children’s development and health\nMerck Selbstmedikation GmbH, Roesslerstrasse 96, 64293 Darmstadt, Germany\nDocosahexaenoic acid (DHA)\nDocosahexaenoic acid (DHA) maternal intake contributes to the normal brain development of the foetus and breastfed infants.\nInformation shall be given to pregnant and lactating women that the beneficial effect is obtained with a daily intake of 200 mg of DHA in addition to the recommended daily intake for omega-3 fatty acids for adults, i.e. 250 mg DHA and EPA.\nThe claim can be used only for food which provides a daily intake of at least 200 mg DHA.\nQ-2008-773",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2011/440/annex/I",
    "retrieved_at": "2026-11-01T14:50:10.588592+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}